No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Avamere Transitional Care & Rehabilitation – Brighton Opens a Dedicated COVID-19 United

Editor: What To Know

  • But at the heart of it all is a team dedicated to living Avamere's mission to enhance the life of every person they serve.
  • Rehabilitation provides a dedicated place for individuals to transition from hospital to home while recovering from the virus, following the recommended 14-day quarantine by the Centers for Disease Control and Prevention.
  • Shad Grubbs and associate extended providers will work with patients one-on-one in the COVID-19 unit, Avamere's Medical Director at the Brighton location and Avamere Transitional Care and Rehabilitation – Malley in Northglenn, Colorado.

The 50-bed unit at Avamere Transitional Care & Rehabilitation provides a dedicated place for individuals to transition from hospital to home while recovering from the virus, following the recommended 14-day quarantine by the Centers for Disease Control and Prevention.

Avamere Transitional Care & Rehabilitation – Brighton calls this the ABC unit, standing for “Avamere Brighton Cares.”

“Being in the healthcare industry, we have the honor of serving seniors in our local community,” stated Rachel Rodriguez, Interim Administrator at Avamere Transitional Care & Rehabilitation – Brighton. “This is our way of helping those who need us most during this crucial time.”

The unit will feature dedicated full-time occupational, physical, and speech therapists, as well as a unit-dedicated hospice team from Dignity Hospice.

Dr. Shad Grubbs and associate extended providers will work with patients one-on-one in the COVID-19 unit, Avamere’s Medical Director at the Brighton location and Avamere Transitional Care and Rehabilitation – Malley in Northglenn, Colorado.

This dedicated unit is unique for senior care communities in Colorado. In fact, state health officials told Avamere they were a pioneer in Colorado.

But at the heart of it all is a team dedicated to living Avamere’s mission to enhance the life of every person they serve.

“Our altruistic goal is to serve the Denver area, serve the community,” stated Dr. Grubbs.

​Avamere Transitional Care & Rehabilitation – Brighton is accepting patients in Brighton, Colorado, and the surrounding areas.


Other hospital-related news items can be found here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy